Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | OpenSAFELY Internal | opensafely-internal-interactive | 16057 | TPP | 9/9 | Brian Mackenna (Gmail) | 3 years ago 07 March 2023 12:14:34 UTC | View, Job request 16057 |
| Succeeded | What was the impact of the COVID-19 pandemic on medication reviews? | medication_reviews | 16052 | TPP | 1/1 | Louis Fisher | 3 years ago 07 March 2023 11:52:28 UTC | View, Job request 16052 |
| Succeeded | OpenSAFELY Internal | opensafely-internal-interactive | 16041 | TPP | 9/9 | Catherine Stables | 3 years ago 07 March 2023 10:31:05 UTC | View, Job request 16041 |
| Succeeded | What was the impact of the COVID-19 pandemic on medication reviews? | medication_reviews | 16036 | TPP | 1/1 | Louis Fisher | 3 years ago 07 March 2023 10:16:09 UTC | View, Job request 16036 |
| Succeeded | What was the impact of the COVID-19 pandemic on medication reviews? | medication_reviews | 16017 | TPP | 1/1 | Louis Fisher | 3 years ago 07 March 2023 09:06:31 UTC | View, Job request 16017 |
| Succeeded | GP appointments during COVID | winter-pressures | 16015 | TPP | 4/4 | Lisa Hopcroft | 3 years ago 07 March 2023 06:55:47 UTC | View, Job request 16015 |
| Failed | GP appointments during COVID | winter-pressures | 16012 | TPP | 7/9 | Lisa Hopcroft | 3 years ago 06 March 2023 20:01:45 UTC | View, Job request 16012 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16007 | TPP | 14/14 | Linda Nab | 3 years ago 06 March 2023 15:06:33 UTC | View, Job request 16007 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15998 | TPP | 14/14 | Linda Nab | 3 years ago 06 March 2023 11:52:18 UTC | View, Job request 15998 |
| Succeeded | What was the impact of the COVID-19 pandemic on medication reviews? | medication_reviews | 15996 | TPP | 1/1 | Louis Fisher | 3 years ago 06 March 2023 18:57:35 UTC | View, Job request 15996 |
| Succeeded | OpenSAFELY Internal | opensafely-internal-interactive | 15992 | TPP | 9/9 | Lucy Bridges | 3 years ago 03 March 2023 17:36:49 UTC | View, Job request 15992 |
| Succeeded | GP appointments during COVID | winter-pressures | 15991 | TPP | 9/9 | Lisa Hopcroft | 3 years ago 03 March 2023 16:16:49 UTC | View, Job request 15991 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15990 | TPP | 4/4 | Linda Nab | 3 years ago 03 March 2023 15:40:12 UTC | View, Job request 15990 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15989 | TPP | 12/12 | Linda Nab | 3 years ago 03 March 2023 15:32:02 UTC | View, Job request 15989 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15988 | TPP | 1/1 | Linda Nab | 3 years ago 03 March 2023 15:03:18 UTC | View, Job request 15988 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15987 | TPP | 32/32 | Linda Nab | 3 years ago 03 March 2023 14:44:39 UTC | View, Job request 15987 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15981 | TPP | 1/1 | Bang Zheng | 3 years ago 03 March 2023 08:56:24 UTC | View, Job request 15981 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15980 | TPP | 1/1 | Bang Zheng | 3 years ago 03 March 2023 08:50:28 UTC | View, Job request 15980 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15979 | TPP | 1/1 | Bang Zheng | 3 years ago 03 March 2023 08:32:22 UTC | View, Job request 15979 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15977 | TPP | 1/2 | Bang Zheng | 3 years ago 03 March 2023 00:21:22 UTC | View, Job request 15977 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15976 | TPP | 1/1 | Bang Zheng | 3 years ago 02 March 2023 23:52:50 UTC | View, Job request 15976 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15975 | TPP | 12/12 | Linda Nab | 3 years ago 02 March 2023 23:47:51 UTC | View, Job request 15975 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15974 | TPP | 1/1 | Bang Zheng | 3 years ago 02 March 2023 23:38:31 UTC | View, Job request 15974 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 15973 | TPP | 2/2 | Linda Nab | 3 years ago 02 March 2023 23:32:47 UTC | View, Job request 15973 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 15972 | TPP | 1/2 | Bang Zheng | 3 years ago 02 March 2023 23:31:37 UTC | View, Job request 15972 |